Surrozen, a biotech company focused on developing Wnt signaling-based treatments for serious eye diseases, announced it will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026. The presentation will include updates on their clinical development programs, including the DUET Phase 1b/2a study for diabetic macular edema and other pipeline candidates. This event offers investors insight into Surrozen's progress and potential impact on ophthalmic therapies. A live webcast will be available on Surrozen's investor website, with a replay archived for 30 days.
Surrozen's upcoming presentation at a healthcare investor conference is the subject, with Pluang market data as context. As of Nov 07, 2026 04:02 WIB, among 150 priced Health-sector US stocks tradable on Pluang, 77 rose and 72 fell. Notable movers include XRAY at USD 8.80 with a -17.37% change and 100% buy order activity, INO at USD 1.22 down -15.86%, and HALO at USD 103.91 down -15.49%.
Arcutis Biotherapeutics awarded 58,500 restricted stock units and options for 17,000 shares to six new employees as an inducement to join the company. The grants, approved under Nasdaq Listing Rule 5635(c)(4), vest over four years with specific sched...
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...
At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...
